Study Evaluating Desvenlafaxine Sustained-Release (DVS-SR) in Adult Outpatients With Major Depressive Disorder
Status:
Completed
Trial end date:
2007-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the antidepressant efficacy, safety, and tolerability
of DVS-SR in subjects receiving daily doses of 50 mg or 100 mg of DVS-SR versus subjects
receiving placebo.